Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Remission of depression in patients with schizophrenia and comorbid major depressive disorder: results from the FACE-SZ cohort.

Fond G, Boyer L, Berna F, Godin O, Bulzacka E, Andrianarisoa M, Brunel L, Aouizerate B, Capdevielle D, Chereau I, Coulon N, D'Amato T, Dubertret C, Dubreucq J, Faget C, Leignier S, Lançon C, Mallet J, Misdrahi D, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Leboyer M, Schürhoff F, Llorca PM; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Br J Psychiatry. 2018 Aug;213(2):464-470. doi: 10.1192/bjp.2018.87. Epub 2018 Jun 6.

PMID:
29871707
2.

[The 10-year findings from the FondaMental Academic Center of Expertise for Schizophrenia (FACE-SZ): Review and recommendations for clinical practice].

Schürhoff F, Fond G, Berna F, Bulzacka E, Godin O, Boyer L, Misdrahi D, Andrianarisoa M, Brunel L, Coulon N, Aouizerate B, Capdevielle D, Chereau I, D'Amato T, Dubertret C, Dubreucq J, Faget C, Gabayet F, Mallet J, Rey R, Lancon C, Passerieux C, Schandrin A, Urbach M, Vidailhet P, Leboyer M, Llorca PM; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Encephale. 2019 Feb;45(1):9-14. doi: 10.1016/j.encep.2018.07.007. Epub 2018 Oct 13. French.

PMID:
30327207
3.

Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.

Fond G, Godin O, Brunel L, Aouizerate B, Berna F, Bulzacka E, Capdevielle D, Chereau I, Dorey JM, Dubertret C, Dubreucq J, Faget C, Gabayet F, Le Strat Y, Micoulaud-Franchi JA, Misdrahi D, Rey R, Richieri R, Passerieux C, Schandrin A, Schürhoff F, Tronche AM, Urbach M, Vidalhet P, Llorca PM, Leboyer M; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

J Affect Disord. 2016 Feb;191:209-15. doi: 10.1016/j.jad.2015.11.017. Epub 2015 Nov 26.

PMID:
26674214
4.

Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohort.

Fond G, Godin O, Schürhoff F, Berna F, Aouizerate B, Capdevielle D, Chereau I, D'Amato T, Dubertret C, Dubreucq J, Faget C, Leignier S, Lançon C, Mallet J, Marulaz L, Misdrahi D, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Leboyer M; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group, Boyer L, Llorca PM.

J Affect Disord. 2019 Feb 15;245:468-474. doi: 10.1016/j.jad.2018.11.004. Epub 2018 Nov 6.

PMID:
30428447
5.

[Use of antidepressant drugs in schizophrenic patients with depression].

Micallef J, Fakra E, Blin O.

Encephale. 2006 Mar-Apr;32(2 Pt 1):263-9. Review. French.

PMID:
16910628
6.

Hypovitaminosis D is associated with depression and anxiety in schizophrenia: Results from the national FACE-SZ cohort.

Fond G, Godin O, Schürhoff F, Berna F, Bulzacka E, Andrianarisoa M, Brunel L, Aouizerate B, Capdevielle D, Chereau I, Coulon N, D'Amato T, Dubertret C, Dubreucq J, Faget C, Lançon C, Leignier S, Mallet J, Misdrahi D, Passerieux C, Rey R, Schandrin A, Urbach M, Vidailhet P, Leboyer M, Boyer L, Llorca PM; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Psychiatry Res. 2018 Dec;270:104-110. doi: 10.1016/j.psychres.2018.09.024. Epub 2018 Sep 13.

PMID:
30245372
7.

The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder.

Wu CH, Erickson SR, Piette JD, Balkrishnan R.

Res Social Adm Pharm. 2012 May-Jun;8(3):193-205. doi: 10.1016/j.sapharm.2011.04.002. Epub 2011 Sep 28.

PMID:
21955808
8.

Prescription of potentially inappropriate psychotropic drugs in homeless people with schizophrenia and bipolar disorders. Results from the French Housing First (FHF) program.

Fond G, Tinland A, Boucekine M, Girard V, Loubière S, Auquier P, Boyer L; French Housing First Study Group.

Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:84-89. doi: 10.1016/j.pnpbp.2018.08.024. Epub 2018 Aug 25.

PMID:
30153497
9.

Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia.

Fond G, Faugere M, Faget-Agius C, Cermolacce M, Richieri R, Boyer L, Lançon C.

Eur Arch Psychiatry Clin Neurosci. 2018 Aug 4. doi: 10.1007/s00406-018-0932-0. [Epub ahead of print]

PMID:
30078128
10.

Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.

Medical Advisory Secretariat.

Ont Health Technol Assess Ser. 2004;4(7):1-98. Epub 2004 Jun 1.

11.

Sexual satisfaction and quality of life in major depressive disorder before and after treatment with citalopram in the STAR*D study.

Ishak WW, Christensen S, Sayer G, Ha K, Li N, Miller J, Nguyen JM, Cohen RM.

J Clin Psychiatry. 2013 Mar;74(3):256-61. doi: 10.4088/JCP.12m07933.

PMID:
23561231
12.

Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.

Iovieno N, Tedeschini E, Bentley KH, Evins AE, Papakostas GI.

J Clin Psychiatry. 2011 Aug;72(8):1144-51. doi: 10.4088/JCP.10m06217. Epub 2011 Apr 19.

PMID:
21536001
13.

[Depressive symptoms during anorexia nervosa: State of the art and consequences for an appropriate use of antidepressants].

Leblé N, Radon L, Rabot M, Godart N.

Encephale. 2017 Feb;43(1):62-68. doi: 10.1016/j.encep.2016.02.017. Epub 2016 Jul 21. Review. French.

PMID:
27452149
14.

Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional study.

Woo JM, Jeon HJ, Noh E, Kim HJ, Lee SW, Lee KK, Kim SH, Hong JP.

Health Qual Life Outcomes. 2014 Dec 18;12:188. doi: 10.1186/s12955-014-0188-y.

15.

Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set.

Fond G, Berna F, Boyer L, Godin O, Brunel L, Andrianarisoa M, Aouizerate B, Capdevielle D, Chereau I, Danion JM, Dubertret C, Dubreucq J, Faget C, Gabayet F, Le Gloahec T, Llorca PM, Mallet J, Misdrahi D, Rey R, Richieri R, Passerieux C, Portalier C, Roux P, Vehier A, Yazbek H, Schürhoff F, Bulzacka E; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group.

Eur Arch Psychiatry Clin Neurosci. 2018 Feb;268(1):17-26. doi: 10.1007/s00406-017-0787-9. Epub 2017 Mar 27.

PMID:
28349247
16.

Metabolic syndrome in patients with bipolar disorder: comparison with major depressive disorder and non-psychiatric controls.

Silarova B, Giltay EJ, Van Reedt Dortland A, Van Rossum EF, Hoencamp E, Penninx BW, Spijker AT.

J Psychosom Res. 2015 Apr;78(4):391-8. doi: 10.1016/j.jpsychores.2015.02.010. Epub 2015 Feb 25.

17.

Prevalence of ADHD symptoms across clinical stages of major depressive disorder.

Bron TI, Bijlenga D, Verduijn J, Penninx BW, Beekman AT, Kooij JJ.

J Affect Disord. 2016 Jun;197:29-35. doi: 10.1016/j.jad.2016.02.053. Epub 2016 Mar 2.

PMID:
26970265
18.

Structural network changes in patients with major depression and schizophrenia treated with electroconvulsive therapy.

Wolf RC, Nolte HM, Hirjak D, Hofer S, Seidl U, Depping MS, Stieltjes B, Maier-Hein K, Sambataro F, Thomann PA.

Eur Neuropsychopharmacol. 2016 Sep;26(9):1465-1474. doi: 10.1016/j.euroneuro.2016.06.008. Epub 2016 Jul 12.

PMID:
27424799
19.

A cross-sectional survey to investigate the prevalence of pain in Japanese patients with major depressive disorder and schizophrenia.

Kishi T, Matsuda Y, Mukai T, Matsunaga S, Yasue I, Fujita K, Okochi T, Hirano S, Kajio Y, Funahashi T, Akamatsu K, Ino K, Okuda M, Tabuse H, Iwata N.

Compr Psychiatry. 2015 May;59:91-7. doi: 10.1016/j.comppsych.2015.02.004. Epub 2015 Feb 17.

PMID:
25724075
20.

Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity.

IsHak WW, Steiner AJ, Klimowicz A, Kauzor K, Dang J, Vanle B, Elzahaby C, Reid M, Sumner L, Danovitch I.

Psychopharmacol Bull. 2018 Jan 15;48(1):8-25.

Supplemental Content

Support Center